Form4insider filings, from the source

SEC Form 4 · accession 0001437749-15-009011

HYPERION THERAPEUTICS INC · HPTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey S Farrow
Officer — CFO
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 1, 2015M24,630$1.28A48,255D
Common StockMay 1, 2015M24,630$1.28A72,885D
Common StockMay 1, 2015M53,184$4.08A126,069D
Common StockMay 1, 2015M17,704$7.31A143,773D
Common StockMay 1, 2015M629$10.95A144,402D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F1$1.28May 1, 2015M24,630D—Apr 14, 2020Common Stock24,6300D
Employee Stock Option (right to buy)F1$1.28May 1, 2015M24,630D—Jun 30, 2020Common Stock24,6300D
Employee Stock Option (right to buy)F1$4.08May 1, 2015M53,184D—Apr 14, 2021Common Stock53,1840D
Employee Stock Option (right to buy)F1$7.31May 1, 2015M17,704D—Apr 15, 2022Common Stock17,70423,346D
Employee Stock Option (right to buy)F1$10.95May 1, 2015M629D—Oct 15, 2022Common Stock62914,371D

Explanation of responses